|
🐜
|
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.
21 auth.
G. Gray,
M. Allen,
Z. Moodie,
G. Churchyard,
L. Bekker,
M. Nchabeleng,
K. Mlisana,
B. Metch,
G. de Bruyn,
M. Latka,
...
S. Roux,
M. Mathebula,
N. Naicker,
C. Ducar,
D. Carter,
A. Puren,
N. Eaton,
M. McElrath,
M. Robertson,
L. Corey,
J. Kublin
|
8 |
2011 |
8
🐜
|
|
🐬
|
Determinants of Enrollment in a Preventive HIV Vaccine Trial: Hypothetical Versus Actual Willingness and Barriers to Participation
S. Buchbinder,
B. Metch,
S. Holte,
S. Scheer,
A. Coletti,
E. Vittinghoff
|
7 |
2004 |
7
🐬
|
|
🐜
|
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.
28 auth.
S. Kalams,
S. Parker,
M. Elizaga,
B. Metch,
Srilatha Edupuganti,
J. Hural,
S. D. De Rosa,
D. Carter,
K. Rybczyk,
I. Frank,
J. Fuchs,
B. Koblin,
Denny H Kim,
P. Joseph,
M. Keefer,
...
L. Baden,
J. Eldridge,
J. Boyer,
Adam I Sherwat,
M. Cardinali,
M. Allen,
M. Pensiero,
C. Butler,
Amir S. Khan,
Jian Yan,
N. Sardesai,
J. Kublin,
D. Weiner
|
7 |
2013 |
7
🐜
|
|
🐜
|
Primary tubal infertility in relation to the use of an intrauterine device.
8 auth.
J. Daling,
N. Weiss,
B. Metch,
W. Chow,
R. Soderstrom,
D. Moore,
...
L. Spadoni,
B. Stadel
|
7 |
1985 |
7
🐜
|
|
🐜
|
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
19 auth.
G. Gray,
G. Gray,
Z. Moodie,
B. Metch,
P. Gilbert,
L. Bekker,
G. Churchyard,
M. Nchabeleng,
K. Mlisana,
F. Laher,
...
S. Roux,
K. Mngadi,
C. Innes,
M. Mathebula,
M. Allen,
M. McElrath,
M. Robertson,
J. Kublin,
L. Corey
|
6 |
2014 |
6
🐜
|
|
🐜
|
Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults
16 auth.
S. Kalams,
S. Parker,
Xia Jin,
M. Elizaga,
B. Metch,
Maggie Wang,
J. Hural,
M. Lubeck,
J. Eldridge,
M. Cardinali,
...
W. Blattner,
M. Sobieszczyk,
V. Suriyanon,
A. Kalichman,
D. Weiner,
L. Baden
|
6 |
2012 |
6
🐜
|
|
🐜
|
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers.
7 auth.
Gary E. Goodman,
Gilbert S. Omenn,
M. Thornquist,
M. Thornquist,
Bernedine Lund,
B. Metch,
...
Ina Gylys-Colwell
|
6 |
1993 |
6
🐜
|
|
🐬
|
Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines.
D. Montefiori,
B. Metch,
M. McElrath,
S. Self,
K. Weinhold,
L. Corey
|
5 |
2004 |
5
🐬
|
|
🐜
|
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.
19 auth.
P. Spearman,
S. Kalams,
M. Elizaga,
B. Metch,
Y. Chiu,
M. Allen,
K. Weinhold,
G. Ferrari,
S. Parker,
M. McElrath,
...
S. Frey,
J. Fuchs,
M. Keefer,
M. Lubeck,
M. Egan,
R. Braun,
J. Eldridge,
B. Haynes,
L. Corey
|
5 |
2009 |
5
🐜
|
|
🐬
|
The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer.
G. Goodman,
M. Thornquist,
M. Kestin,
B. Metch,
G. Anderson,
G. Omenn
|
5 |
1996 |
5
🐬
|
